STOCK TITAN

DelphX Announces Closing of Non-Brokered Unit Private Placement

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
private placement

DelphX Capital Markets (OTCQB: DPXCF) closed a non-brokered private placement on November 14, 2025, issuing 1,200,000 units at C$0.05 per unit for gross proceeds of C$60,000. Each unit includes one common share and one warrant.

Each warrant is exercisable for one common share at $0.08 for two years from issuance. Completion remains subject to TSX Venture Exchange approval. Securities are subject to a hold period of four months plus one day. Net proceeds are intended for general corporate purposes.

Loading...
Loading translation...

Positive

  • Gross proceeds of C$60,000 raised
  • Issued 1,200,000 units at C$0.05 per unit
  • Warrants exercisable at $0.08 for two years

Negative

  • Potential shareholder dilution from 1,200,000 new shares
  • Warrants could dilute up to 1,200,000 shares if exercised
  • Closing subject to TSXV approval

News Market Reaction

-5.88%
1 alert
-5.88% News Effect

On the day this news was published, DPXCF declined 5.88%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Toronto, Ontario--(Newsfile Corp. - November 14, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it has closed its non-brokered private placement previously announced on November 12, 2025, issuing 1,200,000 units (the "Units") at a subscription price of C$0.05 per Unit, for gross proceeds of C$60,000 ("the Offering"). Each Unit will consist of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each Warrant will entitle the holder to purchase one Common Share at a price of $0.08, for a period of two years from the date of issuance.

Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.

DelphX intends to use the net proceeds from the Offering in connection with general corporate purposes.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

  • Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
  • Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274664

FAQ

What did DelphX (OTCQB: DPXCF) announce on November 14, 2025?

DelphX closed a non-brokered private placement issuing 1,200,000 units at C$0.05 for gross proceeds of C$60,000.

What does each DelphX unit include in the November 14, 2025 offering?

Each unit includes one common share and one warrant to purchase one common share at $0.08 for two years.

How will DelphX use the proceeds from the November 14, 2025 placement (DPXCF)?

DelphX intends to use net proceeds for general corporate purposes.

When do the warrants from DelphX's November 14, 2025 placement expire?

Each warrant expires two years from the date of issuance.

Are the securities from DelphX's private placement immediately tradable?

No; securities are subject to a hold period of four months plus one day from issuance.

Is DelphX's November 14, 2025 financing final?

Completion is subject to TSX Venture Exchange approval.
Delphx Cap Mkts

OTC:DPXCF

DPXCF Rankings

DPXCF Latest News

DPXCF Stock Data

8.79M
154.03M
30.18%
14.64%
Capital Markets
Financial Services
Link
Canada
Toronto